Does circulating tumor DNA apply as a reliable biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma?

Oral cavity cancer is the most common type of head and neck cancer. There is no definitive standard diagnosis, prognosis, or treatment response biomarker panel based on simple, specific, non-invasive, and reliable methods for head and neck squamous cell carcinoma (HNSCC) patients. On the other hand, the frequent post-treatment biopsies make it challenging to discriminate residual disease or recurrent tumors following postoperative reparative and post-radiation changes. Saliva, blood plasma, and serum samples were commonly used to monitor HNSCC through liquid biopsies. Based on the evidence, the most prominent molecular-based fluid biomarker, such as circulating tumor DNA (ctDNA), has potential applications for early cancer diagnosis, screening, patient management, and surveillance. ctDNA showed genomic and epigenomic changes and the status of human papillomavirus (HPV) with the real-time monitoring of tumor status through cancer therapy. Due to the intra and inter-tumor heterogeneity of tumor cells like cancer stem cells (CSCs) and tumor microenvironment (TME) in HNSCC, the tiny tissue biopsy cannot reflect all genomic and transcriptomic abnormality. Most liquid biopsies are applied to detect circulating molecular biomarkers consisting of cell-free DNA (cfDNA), ctDNA, microRNA, mRNA, and exosome for monitoring tumor progression. Based on the results of previous studies, liquid biopsy can be applied for comprehensive multi-omic discovery by assessing the predictive value of ctDNA in both early and advanced cancers. Liquid biopsy can be used to evaluate molecular signature profiles in HNSCC patients, with great potential to help in early diagnosis, prognosis, surveillance, and treatment monitoring of tumors. These happen by designing longitudinal extensive cohort studies and the utility of organoid technology that promotes the context of personalized and precision cancer medicine.

The effects of biological and chemical silver nanoparticles along with aerobic and anaerobic training protocols on tissues: Morphological and histopathological evaluation.

Nanotechnology and its byproducts are used increasingly considering its global nanotechnology market size and many applications in the health field. The aim of the present study was to investigate the effect of aerobic and anaerobic exercises on cellular uptake of nanoparticles in body tissues. Fusarium oxysporum was used to synthesize biological AgNPs in silver nitrate solution and UV-vis spectrophotometer; XRD and TEM were used to confirm production of nanoparticles. Moreover, 45 male Wistar rats were purchased and randomly divided into 9 equal groups including healthy control groups, aerobic preparation, anaerobic preparation, biological AgNPs, chemical AgNPs, biological AgNPs+aerobic preparation, biological AgNPs+anaerobic preparation, chemical AgNPs+ aerobic preparation, chemical AgNPs+anaerobic preparation. In order to induce aerobic and anaerobic preparation and to create tissue adaptations, male rats completed two types of aerobic and anaerobic protocols three sessions per week for 10 weeks. At the end of the study, sampling was done for histopathology study. The size and shape of AgNPs was 20-30 nm and spherical to polygonal, respectively. The results showed that anaerobic exercise was significantly effective in weight loss. The chemical nanoparticle group led to more intensive tissue degradation in all variables and there were no significant tissue changes in the aerobic, anaerobic, the biological nanoparticles + aerobic and anaerobic groups. It seems that biological AgNPs are more effective than chemical AgNPs on body tissues and chemical AgNPs lead to more tissue damage in most variables. RESEARCH HIGHLIGHTS: There were severe degradative histological effects in the chemical AgNPs groups compare biological AgNPs groups, in terms of most variables.

A cross-sectional study to test equivalence of low- versus intermediate-flip angle dynamic susceptibility contrast MRI measures of relative cerebral blood volume in patients with high-grade gliomas at 1.5 Tesla field strength.

Introduction: 1.5 Tesla (1.5T) remain a significant field strength for brain imaging worldwide. Recent computer simulations and clinical studies at 3T MRI have suggested that dynamic susceptibility contrast (DSC) MRI using a 30° flip angle ("low-FA") with model-based leakage correction and no gadolinium-based contrast agent (GBCA) preload provides equivalent relative cerebral blood volume (rCBV) measurements to the reference-standard acquisition using a single-dose GBCA preload with a 60° flip angle ("intermediate-FA") and model-based leakage correction. However, it remains unclear whether this holds true at 1.5T. The purpose of this study was to test this at 1.5T in human high-grade glioma (HGG) patients. Methods: This was a single-institution cross-sectional study of patients who had undergone 1.5T MRI for HGG. DSC-MRI consisted of gradient-echo echo-planar imaging (GRE-EPI) with a low-FA without preload (30°/P-); this then subsequently served as a preload for the standard intermediate-FA acquisition (60°/P+). Both normalized (nrCBV) and standardized relative cerebral blood volumes (srCBV) were calculated using model-based leakage correction (C+) with IBNeuro™ software. Whole-enhancing lesion mean and median nrCBV and srCBV from the low- and intermediate-FA methods were compared using the Pearson's, Spearman's and intraclass correlation coefficients (ICC). Results: Twenty-three HGG patients composing a total of 31 scans were analyzed. The Pearson and Spearman correlations and ICCs between the 30°/P-/C+ and 60°/P+/C+ acquisitions demonstrated high correlations for both mean and median nrCBV and srCBV. Conclusion: Our study provides preliminary evidence that for HGG patients at 1.5T MRI, a low FA, no preload DSC-MRI acquisition can be an appealing alternative to the reference standard higher FA acquisition that utilizes a preload.